| Product Code: ETC8136316 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia RNA Targeting Small Molecule Drug Discovery Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia RNA Targeting Small Molecule Drug Discovery Market - Industry Life Cycle |
3.4 Malaysia RNA Targeting Small Molecule Drug Discovery Market - Porter's Five Forces |
3.5 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Malaysia RNA Targeting Small Molecule Drug Discovery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in the pharmaceutical sector in Malaysia |
4.2.2 Growing prevalence of RNA-targeted diseases leading to demand for small molecule drug discovery |
4.2.3 Technological advancements in RNA targeting and small molecule drug discovery techniques |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent approval processes for RNA-targeted small molecule drugs |
4.3.2 Limited availability of skilled professionals in RNA targeting and small molecule drug discovery field |
5 Malaysia RNA Targeting Small Molecule Drug Discovery Market Trends |
6 Malaysia RNA Targeting Small Molecule Drug Discovery Market, By Types |
6.1 Malaysia RNA Targeting Small Molecule Drug Discovery Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Cancer, 2021- 2031F |
6.1.4 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.5 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Metabolic Diseases, 2021- 2031F |
6.1.6 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Neurological Diseases, 2021- 2031F |
6.1.7 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market, By End-User |
6.2.1 Overview and Analysis |
6.2.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F |
6.2.3 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.2.4 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenues & Volume, By Others, 2021- 2031F |
7 Malaysia RNA Targeting Small Molecule Drug Discovery Market Import-Export Trade Statistics |
7.1 Malaysia RNA Targeting Small Molecule Drug Discovery Market Export to Major Countries |
7.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Imports from Major Countries |
8 Malaysia RNA Targeting Small Molecule Drug Discovery Market Key Performance Indicators |
8.1 Research funding allocated specifically for RNA targeting small molecule drug discovery projects in Malaysia |
8.2 Number of patents filed for RNA-targeted small molecule drugs in Malaysia |
8.3 Rate of adoption of RNA targeting technologies in pharmaceutical research and development in Malaysia |
9 Malaysia RNA Targeting Small Molecule Drug Discovery Market - Opportunity Assessment |
9.1 Malaysia RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Malaysia RNA Targeting Small Molecule Drug Discovery Market - Competitive Landscape |
10.1 Malaysia RNA Targeting Small Molecule Drug Discovery Market Revenue Share, By Companies, 2024 |
10.2 Malaysia RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here